The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
You are here: Home / Product Recalls / CPSC Press Releases / Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
About The CPSC
CPSC is charged with protecting the public from unreasonable risks of injury or death associated with the use of the thousands of types of consumer products under the agency's jurisdiction.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply